Literature DB >> 25865652

[Comparative study of clinical features between unilateral and bilateral orbital IgG4-related disease].

I Coloma-González1, A Ceriotto2, J Flores-Preciado2, S Corredor-Casas2, G Salcedo-Casillas2.   

Abstract

OBJECTIVE: Descriptive and comparative study of patients with orbital IgG4-related disease.
MATERIAL AND METHODS: A review and analysis of the cases diagnosed with inflammatory orbital lesion related to IgG4 by the Ophthalmic Pathology Service in the Dr. Luis Sánchez Bulnes Hospital.
RESULTS: A total of 9 cases were found, in which 66% were women, and with a mean age of 48 years and time to diagnosis of 2 years. Unilateral involvement was observed in 56% of cases. All the females experienced pain, and there was an optimal response to corticosteroid treatment in 100% of patients who required medical treatment (one case showed spontaneous resolution). In bilateral cases (44%), only 25% were female, and none had pain as a presenting symptom. Furthermore, 25% of these patients required a combination with immunosuppressants to control inflammation.
CONCLUSIONS: Clinical presentation of patients with unilateral orbital IgG4-related disease differs from those with bilateral involvement.
Copyright © 2014 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Dacrioadenitis; Dacryoadenitis; Enfermedad asociada a IgG4; Enfermedad de Mikulicz; Enfermedad inflamatoria de la órbita; IgG4-related disease; Inflammatory orbital disease; Mikulicz's disease; Orbital tumor; Tumor orbitario

Mesh:

Substances:

Year:  2015        PMID: 25865652     DOI: 10.1016/j.oftal.2015.02.018

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  1 in total

1.  IgG4-related disease in an adolescent with radiologic-pathologic correlation.

Authors:  Renato Cesar Ferreira da Silva; Scott M Lieberman; Henry T Hoffman; Bruno Policeni; Amani Bashir; Richard J H Smith; T Shawn Sato
Journal:  Radiol Case Rep       Date:  2016-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.